ENVUE MEDICAL INC NEW
FEED
FEED was delisted on the 15th of September, 2026.
12 hedge funds and large institutions have $149K invested in ENVUE MEDICAL INC NEW in 2026 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 6 closing their positions.
190% more capital inflows, than outflows
Capital inflows: $297K | Capital outflows: $102K
19.44% more ownership
Funds ownership: 7.3% → 26.74% (+19%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
8% less funds holding
Funds holding: 13 → 12 (-1)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HRT Financial
New York
|
+$131K |
| 2 |
Virtu Financial
New York
|
+$108K |
| 3 |
Jane Street
New York
|
+$42.5K |
| 4 |
Two Sigma Securities
New York
|
+$11.6K |
| 5 |
Tower Research Capital (TRC)
New York
|
+$2.21K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Schonfeld Strategic Advisors
New York
|
-$32.2K |
| 2 |
Morgan Stanley
New York
|
-$23.8K |
| 3 |
IAIM
International Assets Investment Management
Orlando,
Florida
|
-$20.7K |
| 4 |
Poehling Capital Management
Madison,
Wisconsin
|
-$17K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$7.85K |
FEED Hedge Fund Activity: Q2 2026 in Review
12 of the 8,374 institutional investors tracked by Wall St. Rank reported a position in ENVUE MEDICAL INC NEW (FEED) for Q2 2026, worth a combined $149K — down 17% from $179K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of FEED and 5 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was HRT Financial, opening a new position worth an estimated $131K. The largest seller was Schonfeld Strategic Advisors, exiting entirely with an estimated $32.2K sold.
- 12 institutional investors held ENVUE MEDICAL INC NEW (FEED) as of Q2 2026, down from 13 in Q1 2026.
- Funds reported $149K of ENVUE MEDICAL INC NEW stock for Q2 2026, down 17% quarter-over-quarter.
- 5 funds opened new ENVUE MEDICAL INC NEW positions in Q2 2026 and 6 closed out, a net change of -1 holder.
- The largest ENVUE MEDICAL INC NEW buyer in Q2 2026 was HRT Financial, an estimated $131K added.
- The largest ENVUE MEDICAL INC NEW seller in Q2 2026 was Schonfeld Strategic Advisors, an estimated $32.2K sold.
Based on aggregated 13F filings for Q2 2026.